Plenary Session 2: IBD
Monday, October 20
2:15 pm – 3:00 pm
MODERATORS: Uma Mahadevan, MD, FACG
Sunanda V. Kane, MD, MSPH, FACG
Oral 16: Safety of Vedolizumab Alone or With Concomitant Corticosteroids and/or Immunosuppressants in Patients With Ulcerative Colitis or Crohn’s Disease
Edward V. Loftus, MD, FACG, Jean-Frederic Colombel, MD, PhD, Corey A. Siegel, MD, James D. Lewis, MD, FACG, Brihad Abhyankar, MBA, Serap Sankoh, PhD, Michael Smyth, MBA, Catherine Milch, MD, Mayo Clinic, Rochester, MN, Icahn School of Medicine at Mount Sinai, New York, NY, Dartmouth-Hitchcock Medical Center, Lebanon, NH, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, Takeda Global Research and Development Centre (Europe) Ltd., London, U.K., Takeda Pharmaceuticals International Co., Cambridge, MA
Embargo Policy
All research presented at the ACG Annual Scientific Meeting is strictly embargoed until 8:00 a.m. on the first day of the Annual Meeting. For 2014, this is Monday, October 20 at 8:00 a.m. EDT.